What Is Type 3 Diabetes? Insulin Resistance In The Brain That Could Trigger Alzheimer’s
Most people are aware of type 1 and type 2 diabetes, but did you know there is a type 3 diabetes as well! It is a more obscure term. Although it is not an accepted medical diagnosis, type 3 diabetes has been discussed in the literature as a possible relationship between insulin resistance in the brain and Alzheimer's disease. This link has been described to help explain how metabolic disorders impact brain health, causing cognitive decline and dementia.
Type 3 diabetes is more of a misnomer because it should not be confused with type 3c diabetes, which relates to pancreatic dysfunction. The term "type 3 diabetes," on the other hand, has been loosely used by some scientists to analogously propose that Alzheimer's disease is strongly implicated with insulin resistance in the brain.
This concept was conceptualized by Dr. Suzanne de la Monte and Dr. Jack Wands of Brown University in the year 2008. This hypothesis postulated that Alzheimer's disease may be called type 3 diabetes for it bears many similarities with glucose metabolism disorder type 2 diabetes. Their concept arises from the basic principle that insulin is fundamental to blood sugar regulation, but it is also the case with the brain. When brain cells become insulin-resistant, they lose access to glucose, impairing their function.
Research published in the Journal of Diabetes Science and Technology supports this hypothesis by indicating that insulin resistance can be a significant contributor to the occurrence of dementia, also referred to as Alzheimer's. The symptoms of memory loss and diminished reasoning are associated with impaired glucose metabolism in the body, especially in the cerebral tissue.
Although type 3 diabetes is not a "medical term," its symptoms correlate well with Alzheimer's diseases that are known to reduce the ability to think in an efficient manner and bring down brain health. These signs are:
- Loss of memory, especially short-term.
- Poor judgment and judgment ability
- Failure in recognizing people or places familiar once.
- Failure in the process of reading, writing or processing numbers
- Anxiety, agitation, or mood changes.
- Disorganized thoughts or confusion
- Lack of impulse control
As the disease advances, patients may be afflicted with severe complications including an inability to swallow or control their bodily functions. In the final stages, most patients die from fatal complications such as aspiration pneumonia.
This may not be well understood with regards to type 3 diabetes, or the exact link between insulin resistance and Alzheimer's disease. Some identified contributing factors include the following:
Insulin acts as an important regulatory mechanism of brain functions such as memory and cognition. The reduction in insulin signaling may impair metabolism of brain cells, thus bringing about neurodegeneration.
These diseases show a strong relationship and those individuals diagnosed with type 2 diabetes have double chances of getting Alzheimer's. In the two, the main causes can be chronic inflammation, oxidative stress, and a defect in glucose metabolism.
Insulin resistance associated with obesity, stress, and an unhealthy diet is considered a cause that may increase the chances of Alzheimer's disease.
Researches in Frontiers in Neuroscience and The Lancet Neurology have also highlighted that drugs used for antidiabetic medication may be crucial for the prevention or at least slowing down the course of Alzheimer's.
In 2022, in a study in Pharmaceuticals, researchers studied biomarker uptake in brain regions implicated in the faulty uptake and metabolism of blood sugar in Alzheimer’s patients.
Emerging Therapies
Research into such treatments as intranasal insulin has also been promising. Intranasal delivery of insulin directly to the brain has been reported to enhance glucose uptake by brain cells, improve memory, and boost cognitive performance. While such clinical trials have been shown to be successful, additional research is needed for safety and efficacy.
Medications
For patients being aggressive or agitated, antipsychotic drugs may be prescribed; however, therapies such as cognitive rehabilitation as well as cognitive stimulation therapy serve to preserve memory and executive function.
Lifestyle Interventions
Diet, exercise, and stress management are critical in preventing and managing insulin resistance. A review in the Journal of Alzheimer's Disease also highlighted the benefits of Kirtan Kriya meditation, which can regulate genes involved in insulin and glucose metabolism, improve sleep, and reduce inflammation.
Although type 3 diabetes is not officially recognized, its connection to Alzheimer’s disease underscores the importance of proactive measures for brain health. Some prevention strategies include:
1. Healthy Diet
Consuming a balanced diet rich in antioxidants, whole grains, and healthy fats may support brain health.
2. Regular Exercise
Physical activity improves insulin sensitivity, reduces inflammation, and enhances overall metabolic health.
3. Stress Reduction
Mindfulness practices, including meditation, have been shown to lower stress levels, which can reduce the risk of cognitive decline.
The term type 3 diabetes brings out the complex relationship between metabolic disorders and brain health. Even though it is not a recognized medical condition, the concept emphasizes the crucial role of insulin in brain function and its possible contribution to Alzheimer's disease. Continued research will hopefully provide hope for therapies such as intranasal insulin and lifestyle modifications.
Credit: AI
Researchers have not been able to pin down one single cause of dementia. From genetics to ageing, there are several factors that come into play when it comes to the risk of degenerative neurological disorders like dementia.
Apart from known factors, a recent study has emerged, suggesting that an individual's social connections with their spouse, family, or other loved ones may influence dementia risk. The study suggests that the quality of social connections, rather than simply whether someone lives alone, may impact dementia risk.
Researchers from the University of Bordeaux in France found that older adults who experience long-term loneliness had a 38% higher risk of developing dementia than those who don't feel lonely. Additionally, occasional loneliness did not have a significant impact on dementia risk.
The findings, published in the journal Aging & Mental Health recently suggest that perpetual feelings of social disconnection may play a role in someone's dementia risk.
The researchers studied data from 3,777 adults aged 65 and older who participated in the French PAQUID study between 1988 and 2018. During the first eight years, participants were examined for loneliness and grouped into three categories:
Researchers then examined dementia diagnoses over a period of 20 years. By the beginning of this second phase, 1,540 participants remained eligible for the analysis. Out of these, at least 560 people developed dementia during follow-up.
The incidence of dementia was the highest among those experiencing chronic loneliness. Around 49.1% of this group developed dementia, compared to 33.1% of those who never reported loneliness. Among participants who experienced occasional loneliness, 34.5% developed dementia.
After accounting for other factors, chronic loneliness was reported to have a 38% higher risk of dementia compared to never experiencing loneliness. Occasional loneliness, however, showed no significant link.
One of the study's main findings was that living with someone does not always guard against loneliness.
Nearly 30% of participants classified as chronically lonely did not live alone. This suggests that people can experience loneliness while living with a spouse, partner or other family members.
Lead author Yvanna Simon said this vulnerability could also arise from unsatisfying relationships, burden of caregiving or a lack of meaningful, satisfying activities.
The researchers suggested several possible ways in which chronic loneliness could impact dementia risk.
Perpetual loneliness may activate the body's stress response over prolonged periods, contributing to inflammation and changes in immune activity.
It may also be contribute to physical inactivity and poor dietary habits, which can increase the risk of cardiovascular disease and diabetes. Both conditions are proven risk factors for dementia.
Less social interaction could also mean fewer opportunities for cognitive stimulation, while prolonged social stress could contribute to biological wear and tear.
It must be understood that the study merely identified a possible connection between chronic loneliness and dementia risk. Another limitation was that loneliness was assessed using a single question about whether participants had felt lonely during the previous week. This may not capture the full complexity of someone's relationships or social experiences.
Credit: Jax Taylor/Instagram
Actor Jax Taylor has opened up about his kidney cancer diagnosis, revealing that what initially appeared to be kidney stones led to the discovery of a tumor on his left kidney.
A CT scan revealed the tumor, which was later diagnosed as cancer.
In a post on Instagram, Taylor revealed undergoing a five-hour surgery to remove it. However, as the tumor was larger than doctors had initially expected, he is awaiting pathology results to determine whether it has all been removed.
Also read: NHS Data Shows 12% Increase In Kidney Cancer In People Under 50: Experts Flag Overlooked Signs
Calling it one of the "scariest times of my life," Taylor said he had kept his diagnosis private for the past few months.
The actor said he woke up one morning in July in severe pain and was taken to the hospital, where doctors investigated him for kidney stones.
"What I thought was just a kidney stone turned into something I never imagined. My CT scan also showed a tumor on my left kidney," he said.
After undergoing several tests and appointments, Taylor learned that the tumor was cancerous. The diagnosis was particularly difficult because he had lost his father to cancer. Hearing the news broke him and put him "in a really dark place," he said.
Taylor described the waiting period as the hardest part of the experience, particularly knowing that a tumor was growing inside him while trying to carry on with everyday life.
He eventually underwent a five-hour surgery to have the tumor removed. However, its size was larger than initially expected, and he is now waiting for pathology results to confirm whether the cancer has been completely removed.
Taylor credited his girlfriend with supporting him throughout the ordeal, calling her his "rock" and best friend.
He also thanked his surgeon, Dr. Adhoot, and the medical team at Cedars-Sinai for their care.
Taylor urged people not to take their health for granted, saying his experience had changed his perspective on life.
"If there's one thing I hope people can take away from this, it's never to take your health for granted. I did for many years and I won't ever do that again," he wrote.
The actor also shared that November 28 would mark his second sobriety anniversary, describing it as a milestone he was extremely proud of.
He reflected on how his kidney stone emergency ultimately led to the discovery of the tumor.
"If I hadn't ended up in the hospital with that kidney stone, I probably wouldn't have known this tumor was there until it was too late," he said.
Taylor added that he likes to think his late father had a part in helping him discover the tumor.
Kidney cancer develops when cells in the kidney begin to grow and divide uncontrollably, forming a tumor.
According to the NHS, kidney cancer may cause the following symptoms:
Kidney cancer does not always cause noticeable symptoms in its early stages. In some cases, tumors are discovered incidentally when a person undergoes imaging tests, such as a CT scan or ultrasound, for an unrelated health problem.
Such incidental findings can help identify kidney tumors before they cause symptoms. However, further tests are needed to determine whether a mass is cancerous and assess its extent.
Credit: AI
Healthcare is undergoing a significant transformation. For decades, medical science has focused primarily on treating diseases and extending life expectancy. Today, however, the conversation is shifting towards a more important question: how can we help people live longer while maintaining good health, physical strength and mental wellbeing?
This shift from lifespan to healthspan is emerging as one of the most important developments in modern healthcare.
Lifespan refers to the total number of years a person lives, while healthspan represents the period during which an individual remains physically active, mentally capable and functionally independent.
Living longer does not necessarily mean living healthier. The increasing prevalence of diabetes, cardiovascular diseases, metabolic disorders and age-related conditions highlights the need to rethink conventional healthcare approaches.
I believe the future of medicine will depend on how effectively we bridge this gap between lifespan and healthspan.
Ageing is a complex biological process influenced by genetics, cellular damage, metabolic changes, environmental exposure and lifestyle factors. Scientific research has identified several mechanisms associated with ageing, including mitochondrial dysfunction, cellular senescence, chronic inflammation and declining stem cell function.
Advancements in biotechnology, molecular biology and regenerative medicine are helping researchers understand these processes more effectively. Biomarkers, metabolic assessments and emerging epigenetic technologies are creating opportunities to study biological ageing and identify potential health risks earlier.
The objective is not to promise immortality or miracle cures, but to understand the biological mechanisms of ageing and develop evidence-based approaches that may help individuals maintain better health for longer.
Regenerative medicine, including research into stem cells, platelet-rich plasma (PRP) and exosomes, is also attracting considerable scientific interest. However, these technologies differ in their clinical evidence, applications and regulatory status. Every intervention must be evaluated through scientific research, patient safety and ethical medical practice.
Also read: Longevity Guide: What Can You Do Today To Reduce Your Risk of Illness 30–40 Years from Now?
India presents a unique opportunity in the global longevity landscape. Its population has distinct genetic, nutritional, metabolic and environmental characteristics. Conditions such as diabetes and cardiovascular diseases also affect many Indians at comparatively younger ages.
Therefore, biological-age assessment tools developed primarily using Western population data may not fully represent ageing patterns among Indian populations.
We need stronger research frameworks that consider India's demographic and biological diversity. Developing population-specific reference standards for biological ageing could help researchers identify relevant biomarkers, understand metabolic differences and improve health assessments.
India also has an opportunity to connect traditional knowledge with contemporary scientific research. Ayurveda has historically emphasised Rasayana, a concept associated with rejuvenation and healthy ageing. While traditional practices must be evaluated through appropriate scientific evidence, exploring their relevance alongside modern biotechnology could encourage interdisciplinary research.
I describe this integration of scientific research, regenerative medicine and intelligent healthcare approaches as Regenerative Intelligence.
One of the most important changes in modern medicine will be the transition from reactive treatment to preventive and predictive healthcare.
Instead of waiting for symptoms to appear, longevity-focused healthcare aims to understand individual health risks earlier through appropriate assessments and lifestyle interventions.
Some essential components include:
Advanced therapies cannot replace these fundamentals. The future of longevity medicine must integrate healthy lifestyle practices, appropriate diagnostics and clinically validated treatments.
Also read: Deepinder Goyal's Temple Device: Why Doctors Are Questioning Its Science
Regenerative medicine is becoming an important area of scientific investigation because it explores biological mechanisms involved in tissue maintenance, repair and regeneration.
Stem cell research, PRP, exosomes and related technologies are being investigated across multiple medical disciplines, including musculoskeletal health, dermatology and women's health.
However, scientific progress must be accompanied by responsible clinical application. Not every promising laboratory finding translates into a safe and effective treatment. Healthcare professionals must understand the underlying science, clinical evidence, limitations and potential risks before considering these interventions.
This makes professional education and research collaboration essential to the responsible growth of regenerative medicine.
The success of longevity medicine will depend not only on scientific discoveries but also on the availability of appropriately trained healthcare professionals.
Recognising this need, the International Association of Stem Cell & Regenerative Medicine (IASRM) has been working to advance professional education, scientific awareness and international collaboration in regenerative and longevity medicine.
Through its Longevity Revolution conferences, initiated in 2014, and its academic initiatives, IASRM provides platforms for interaction among clinicians, scientists, researchers and healthcare professionals. Its fellowship programmes focus on three key areas:
These programmes incorporate international faculty interactions, academic masterclasses, practical training, mentorship and research-oriented learning.
The objective is to strengthen scientific understanding and encourage responsible clinical decision-making. Professional fellowships are educational programmes and do not replace recognised medical qualifications or statutory licensing requirements.
Also read: Times Network India Health Summit 2026 Key Takeaways: AI, Fertility, AYUSH, Cancer Care And More
As longevity medicine gains popularity, distinguishing scientific progress from commercial hype has become increasingly important.
The growing demand for anti-ageing treatments and regenerative procedures has created opportunities for innovation, but it has also increased the risk of misleading claims and inappropriate clinical applications.
Every intervention must be evaluated according to the quality of available evidence. Laboratory research, animal studies, observational research and randomised controlled trials provide different levels of evidence and should not be presented as equivalent.
At IASRM, we believe the future of regenerative and longevity medicine must be guided by three fundamental principles: scientific evidence, ethical practice and continuous professional education.
India has the potential to become an important contributor to global longevity research through its growing biotechnology ecosystem, medical institutions, scientific talent and diverse population.
However, leadership will require sustained investment in research infrastructure, clinical studies, interdisciplinary collaboration and professional training.
The upcoming Healthspan Standard Summit, scheduled for 10–11 April 2027 in New Delhi, will bring together international experts to discuss scientific evidence, clinical relevance, regenerative medicine and the future of healthy ageing.
Such platforms can strengthen collaboration and encourage greater accountability in this rapidly evolving field.
Longevity should not be viewed as an attempt to remain young indefinitely. It should be understood as an effort to preserve health, independence, mobility and quality of life as people grow older.
I believe the next era of healthcare will be defined by the integration of preventive medicine, biotechnology, regenerative science and personalised healthcare.
We have spent decades extending human lifespan. The next great responsibility of medicine is to make those additional years healthier, more active and more meaningful.
© $2026 Times Horizon Private Limited